Increasing incidence rates of atherosclerosis, heart valve issues, arrhythmias, diabetes and cardiomyopathy are some key factors driving demand for congestive heart failure treatment devices in coming six years. Approximately 5.1 million people in the U.S. have heart failure. Lifestyle habits such as smoking, lack of physical activity, unhealthy dietary habits are also increasing the incidences of congestive heart failure. Moreover, increasing geriatric population base is also expected to fuel the prevalence of congestive heart failure thereby propelling growth of this market in the forecast period.
Full research report on Global Congestive Heart Failure Treatment Devices Market with detailed figures and charts available at:
Cardiac assist devices (CAD) held one of the largest shares in congestive heart failure treatment devices market due to the shortage of heart donors and technologically advanced cardiac assist devices in 2013. Additionally, reimbursement coverage for cardiac device implantation procedures is anticipated to provide this segment with growth platform. North America dominated the overall market in terms of revenue owing to the increasing incidence rates of high blood pressure, arthritis, coronary artery disease leading to congestive heart failure. Moreover increasing patient awareness and improved healthcare infrastructure in the U.S. and Canada are expected to drive the market of this region at a rapid rate. Asia pacific market is expected to be the fastest growing market over the next six years. Increasing geriatric population base, presence of high unmet needs and untapped opportunity in emerging countries such as China and India are some drivers contributing to the growth of Asia Pacific market.
Get more information on Global Congestive Heart Failure Treatment Devices Market or request for TOC of this research report at:
Key market players of congestive heart failure treatment devices market are Boston Scientific, World Heart Corporation, St. Jude Medical Inc, Thoratec, cardioelectronica, Baikal, Medtronic Inc., Berlin Heart Inc., AbioMed, Placetronix and Jarvik Heart.
View more reports of this category by Grand View Research at:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information, visit: http://www.grandviewresearch.com/
Company Name: Grand View Research, Inc.
Contact Person: Sherry James
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States